Digestive System Gastroesophageal Reflux Disease

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Gastroesophageal Reflux Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Gastroesophageal Reflux Disease Projects
--AGI Therapeutics plc
--Addex Pharmaceuticals SA
--Axcan Pharma Inc.
--AstraZeneca Plc
--Depomed Inc
--Ception Therapeutics
--Eisai Co Ltd
--Dr Reddys Laboratories Ltd
--Mitsubishi Tanabe Pharma Corporation
--GlaxoSmithKline plc
--Nycomed
--Mylan, Inc.
--Receptor BioLogix, Inc.
--Orexo AB
--Taiho Pharmaceutical Co., Ltd.
--Salix Pharmaceuticals Ltd
--Vecta Ltd.
--Takeda Pharmaceutical Company Limited
--Xenoport Inc
--Wyeth

--Top Companies in early stage Gastroesophageal Reflux Disease Projects
--Addex Pharmaceuticals SA
--AstraZeneca Plc
--Dynogen Pharmaceuticals, Inc.
--Kosan Biosciences Incorporated
--MOVETIS NV
--Pfizer Inc
--Takeda Pharmaceutical Company Limited

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View